(Q35136787)

English

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Serge Sevy

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Delbert G Robinson

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Suzanne Sunday

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Barbara Napolitano

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rachel Miller

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Joanne McCormack

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

John Kane

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Psychiatry Research

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

188

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

310-314

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Comorbid substance use and age at onset of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

28 July 2018

The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

28 July 2018

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

28 July 2018

Intervention research in psychosis: issues related to clinical assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

28 July 2018

Substance abuse and the onset of schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

28 July 2018

The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

28 July 2018

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Substance misuse in first-episode psychosis: 15-month prospective follow-up study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Prevalence of substance misuse in first-episode psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

27 September 2018

Substance use in a population-based clinic sample of people with first-episode psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146636

16 November 2018

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21636134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/21636134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21636134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21636134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21636134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.PSYCHRES.2011.05.001

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35136787&oldid=1641043279"